JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russell, J.
Right arrow Articles by Ling, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russell, J.
Right arrow Articles by Ling, C. C.
Journal of Nuclear Medicine Vol. 43 No. 5 671-677
© 2002 by Society of Nuclear Medicine


Basic Science Investigations

Iodination of Annexin V for Imaging Apoptosis

James Russell, PhD1, Joseph A. O’Donoghue, PhD1,2, Ron Finn, PhD1, Jacek Koziorowski, PhD1,3, Shutian Ruan, MD1, John L. Humm, PhD1 and C. Clifton Ling, PhD1

1 Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
2 Department of Radiation Oncology, University of Glasgow, Glasgow, Scotland
3 Radioisotopes and Irradiation Services, Studsvik Nuclear AB, Nyküping, Sweden

Our goal in this investigation was to develop a method for iodinating annexin V that would be suitable for the in vivo detection of apoptosis. Methods: Annexin V was iodinated with 125I using 2 different techniques: direct iodination with IODO-BEADS, resulting in the iodination of tyrosine residues; and use of the Bolton-Hunter reagent, which binds to lysine. The active fraction of the labeled preparation was purified by affinity chromatography. We assessed thyroid accumulation of free iodide by comparing mice with blocked and unblocked thyroids. We tested the ability of iodinated annexin V to bind apoptotic cells in vitro using irradiated neuroblastoma cells and immobilized phosphatidylserine and in vivo using C3H mice subjected to whole-body irradiation. Results: The efficiency of IODO-BEADS iodination was just below 30%; with the Bolton-Hunter protocol we were able to achieve 40% efficiency. When the IODO-BEADS-labeled preparation was injected into nude mice, activity accumulated rapidly in the thyroid. Two hours after injection, uptake in the thyroid region was clearly visible on a gamma-camera scan. This uptake was absent in mice that had had their thyroids blocked. We concluded that the IODO-BEADS method of labeling resulted in a protein that was rapidly deiodinated in vivo. By contrast, when annexin V was labeled using the Bolton-Hunter protocol, there was no evidence of activity accumulating in the thyroid. The Bolton-Hunter-labeled annexin V bound to apoptotic cells and immobilized phosphatidylserine in vitro. The active fraction of Bolton-Hunter-labeled annexin V was approximately 0.75. In C3H mice given 5-Gy whole-body irradiation, there was a significant induction of apoptosis in the spleen, as measured by the terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick-end labeling assay, and a 4-fold increase in 125I activity in the spleens relative to that of the control animals. Conclusion: Direct iodination of annexin V on tyrosine residues is a poor technique suffering from rapid deiodination in vivo. With Bolton-Hunter chemistry, one can produce a molecule that retains its label in vivo and binds to apoptotic cells in vitro and in vivo.

Key Words: apoptosis • Bolton-Hunter chemistry • annexin V • iodination




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. E. Testa, A. Chrastina, P. Oh, Y. Li, H. Witkiewicz, M. Czarny, T. Buss, and J. E. Schnitzer
Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo
Am J Physiol Lung Cell Mol Physiol, August 1, 2009; 297(2): L251 - L262.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S. Biswal, D. L. Resnick, J. M. Hoffman, and S. S. Gambhir
Molecular Imaging: Integration of Molecular Imaging into the Musculoskeletal Imaging Practice
Radiology, September 1, 2007; 244(3): 651 - 671.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. H. Boersma, B. L.J.H. Kietselaer, L. M.L. Stolk, A. Bennaghmouch, L. Hofstra, J. Narula, G. A.K. Heidendal, and C. P.M. Reutelingsperger
Past, Present, and Future of Annexin A5: From Protein Discovery to Clinical Applications
J. Nucl. Med., December 1, 2005; 46(12): 2035 - 2050.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Petrovsky, E. Schellenberger, L. Josephson, R. Weissleder, and A. Bogdanov Jr.
Near-Infrared Fluorescent Imaging of Tumor Apoptosis
Cancer Res., April 15, 2003; 63(8): 1936 - 1942.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. W. Vannier
Imaging Apoptosis in Rheumatoid Arthritis
J. Nucl. Med., October 1, 2002; 43(10): 1366 - 1367.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.